To explore the relationship between genetic factors, lifestyle, and drug interventions and the occurrence, development, adverse pregnancy outcomes, and postpartum maternal-infant outcomes of gestational endocrine diseases.
Women preparing for pregnancy or pregnant women or within 1 year after giving birth
Age ≥ 18 years old
Signed the informed consent form to voluntarily enroll in the management follow-up
Individuals who are unable to communicate normally and those who are unwilling to cooperate
Pregnant women with severe organic diseases or mental illnesses
Any condition deemed by the investigator to affect eligibility for the study
Shanghai General Hospital, China
Lead sponsor